HISTORY AND PHYSICAL EXAMINATION
A 71-year-old woman with a medical history of hypertension, hyperlipidemia, diverticulosis, and microscopic hematuria with a negative intravenous pyelogram (IVP) originally presented to an outside institution with 4 months of gradually increasing right upper quadrant abdominal pain. She reported subjective weight loss, chills, night sweats, and fatigue but denied any bowel or urinary symptoms, weakness, or changes in sensation. At that time she was evaluated extensively by gastroenterologists looking for a cause of her abdominal pain. Multiple endoscopic studies, right upper quadrant ultrasound, technetium 99m-DISIDA scan of the gall bladder, small bowel series, and computed tomography (CT) scans of the abdomen and pelvis were all completed with no explanation of her symptoms. A bone scan showed a focus of increased uptake in the cervical region on the right side posteriorly, a finding attributed to degenerative disc disease. There was no evidence of metastatic disease. A mammogram performed at this time was negative.
Six months after her initial symptoms, the pain began to include her back. A chest radiograph showed sclerosis in the ninth thoracic vertebral body with a slight loss of height and no pulmonary opacities. Because of these findings, MRI of the thoracic spine was obtained, which showed a destructive lesion of the ninth thoracic vertebral body with extension into the right posterior elements, neural foramina (right greater than left), and extension into the right paraspinal soft tissues with severe cord compression. After the MRI, the patient was immediately hospitalized and a CT-guided needle biopsy was performed 2 months before presenting to our institution, 6 months after initial presentation. Sections of the biopsy material showed the presence of small round blue cells that stained positively for CD99 and weakly for vimentin. The biopsy specimens stained negatively for CD43 and CK-18. However, insufficient tissue was obtained for performing cellular reverse transcriptase polymerase chain reaction (RT-PCR) studies.
The lesion was presumed to represent a metastasis from an unknown primary neoplasm, and she received 10 treatments of radiation totaling 3000 cGy. She reported the treatments gave her some relief of her abdominal and back pain. A post radiation therapy CT scan showed a slight decrease in spinal cord compression.
Eight months after initial presentation and 2 weeks before presenting to our institution, a repeat bone scan was performed, showing an area of increased uptake in the T9 vertebral body consistent with the location of the lesion without substantial uptake elsewhere. After being referred to our orthopaedic oncology service, the patient denied back pain but acknowledged a 40-pound weight loss in the last few months, night sweats, and a reduction in appetite. The patient denied lower extremity weakness and bowelbladder dysfunction. On clinical exam, her systemic and neurovascular examinations were normal. Although she had some difficulty moving unassisted secondary to a thoracolumbosacral orthosis (TLSO) brace, she had no focal sensory or motor deficits. She had point tenderness with no palpable lymphadenopathy.
Additional imaging studies including plain radiographs, a bone scan (Fig 1) , CT imaging ( Fig 2) , and MRI (Fig 3) were also completed before the second biopsy. The patient's original outside biopsy material could not be located by the institution that obtained it. As a result, the patient underwent a second biopsy because more tissue was needed to perform cellular RT-PCR studies to confirm the diagnosis. One week after the second biopsy, the patient was admitted to our hospital's neurosurgery service for acute lower extremity weakness and loss of sphincter tone. She was taken to the operating room for emergent decompression. After a short stay in the intensive care unit, she was discharged to the floor and chemotherapy initiated.
Based on the history, physical examination, laboratory tests, and imaging studies, what is the differential diagnosis? 
IMAGING INTERPRETATION
The lateral and two anteroposterior (AP) radiographs of the thoracic spine reportedly showed an anterior and right lateral compressive deformity of the T9 vertebral biopsy, corresponding to the site of the known osseous lesion.
The technetium 99m-labeled MDP total body bone scan showed intense radiotracer activity corresponding to the site of the known T9 vertebral body lesion (Fig 1) . There was no scintigraphic evidence for other foci of osseous metastatic disease. A CT scan of the chest, abdomen, and pelvis showed no pulmonary nodules or suspicious lesions. The destructive lesion at the T9 level extended into the spinal canal and into the right paravertebral soft tissues ( Fig 2) . No other lytic or sclerotic lesions were seen within the thorax. A Type II aortic dissection was also noted. There was no hilar, mediastinal, or axillary adenopathy.
The MRI without gadolinium contrast showed a mass in the T9 vertebral body extending into both neural foramina, the right posterior elements, and right paraspinal soft tissues. The mass extended into the spinal canal causing stenosis and cord compression; however, the cord was of normal caliber with no abnormal intrasubstance signal to suggest edema or myelomalacic change. There was a mild pathologic compression fracture of the T9 vertebral body. An ectatic thoracic aorta with a Type II dissection extending into the upper abdomen was also noted. Metastatic disease was suspected, but a primary skeletal lesion was not ruled out.
The subsequent thoracic spine MRI with and without gadolinium contrast displayed an enhancing 5.5 × 4.1 × 3.2 cm mass (no notable increase in size from the MRI 1 month previously) with slightly decreased cord compression. The mass showed an interval increase of T2 intensity potentially related to edema, radiation therapy, or necrosis (Fig 3) . There had been a slight progression of the pathologic compression fracture involving the T9 vertebral body, which was worse on the right side.
DIFFERENTIAL DIAGNOSIS
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Myelomatous lesion Metastatic carcinoma Infection Ewing's sarcoma Primary sarcoma
A second biopsy was performed to obtain tissue for cellular RT-PCR studies and to confirm the pathologic diagnosis from the needle biopsy. Based on the history, physical findings, laboratory tests, radiographic studies, and histologic picture, what is the diagnosis and how should this lesion be treated? Continuation of ORP conference from page 344.
HISTOLOGY INTERPRETATION
Histologic examination of the paraspinal mass obtained from the first needle biopsy at the outside institution revealed malignant small, round, blue tumor cells. The tumor cells were positive for only CD99 and weakly for vimentin. The tissue was negative for multiple epithelial markers (AE1/AE3, CK7, CK20, CK19, EMA), lymphoid markers (LCA, Kappa, lambda, CD38, CD3, CD20), melanoma markers (S100, HMB-45), and neuroendocrine markers (chromogranin, synaptophysin).
The second biopsy of the intraspinal mass showed lobules of monotonous population of small, round, blue cells with vesicular chromatin and prominent nucleoli ( Fig 4) in a background of fibrovascular tissue and with a focus of tumor necrosis. Immunostains were positive for CD99 ( Fig 5) and O13, weakly positive for vimentin, and negative for epithelial markers including CAM 5.2, AE1/AE3, and EMA, neuroendocrine markers chromogranin and synaptophysin, and for the muscle markers desmin and myogenin. Flow cytometry revealed small population lymphocytes (4%), predominantly T-cells, and a population of cells negative for CD45 leukocyte common antigen (70%) with dim CD56 and CD138 expression. Reverse transcription polymerase chain reaction assays for molecular diagnosis of sarcoma-associated gene fusions revealed Ewing's sarcoma with translocation t(11;22)(q24;q12) corresponding to fusion product EWS-FLI1, and t(21;22)(q22;q12) corresponding to fusion product EWS-ERG.
DIAGNOSIS
Ewing's sarcoma
DISCUSSION AND TREATMENT
In 1921, James Ewing originally described a tumor of long bones that, in contrast to osteosarcoma, was sensitive to radiation. 10 Though the suggestion of the tumor being of endothelial origin was widely held until the mid-1980s, recent evidence suggests Ewing's sarcoma has a neural origin. 13 The most common form of Ewing's sarcoma is of bone but it may also arise from soft tissues. Peripheral primitive neuroectodermal tumor or neuroepithelioma are thought to be more differentiated forms of Ewing's sarcoma occurring as a primary tumor of bone or soft tissue, 13 but Ewing's sarcoma cells grown in culture show no evidence of differentiation. On gross pathologic inspection, Ewing's sarcoma tumors are soft, pink-to-gray masses frequently with foci of hemorrhage and necrosis. An extraosseous portion of the neoplasm is present in more than 80% of cases and is usually much larger than the intraosseous component. 20 According to Unni et al, 25 the pathological trend is to consider all highly malignant, small, round-tooval cell sarcomas as belonging to the Ewing's family of tumors.
Without a definitive diagnosis from the original biopsy, the most common diagnoses to be considered, especially in older patients, are metastatic carcinoma, lymphoma, and myeloma, although infections and primary sarcomas should be considered. Lymphoma is a permeative but minimally destructive lesion. Plain radiographs may be remarkably normal while MRI scans show marrow replacement and often an associated large soft tissue mass similar to Ewing's sarcoma. Lymphoma was thought to be the most likely diagnosis, especially after the original pathologic specimen consisted of round cells, but RT-PCR proved otherwise.
As a result of the patient's advanced age, metastatic carcinoma was high as a differential diagnosis. Metastatic carcinoma is the most common cause of aggressive destructive lesions in adults and can take on a variety of appearances from lytic to blastic. It frequently occurs as multiple lesions and may be the first presentation of the underlying neoplasm. The outside institution believed this was a metastatic lesion, but this was considered less likely after discovering no primary source.
Myeloma frequently appears as solitary or multiple medullary lytic lesions with sharp margins but little reaction on imaging. The diagnosis usually is made based on history, physical examination, laboratory findings, plain radiographs, and ultimately biopsy. On plain radiographs, solitary bone plasmacytoma has a lytic appearance, commonly referred to as soap bubble lesions, with clear margins and a narrow zone of transition to normal surrounding bone. 5, 7, 8 Skeletal survey is important to exclude other sites of skeletal involvement and differentiate between solitary bone plasmacytoma and multiple myeloma. Computed tomography and particularly MRI depict the extent of solitary bone plasmacytoma more clearly. 1, 8 On MRI, solitary bone plasmacytoma appears as a focal area of bone marrow replacement with the signal intensity being similar to muscle on T1-weighted images and hyperintense relative to muscle on T2-weighted images. 8 Myeloma was considered less likely in this patient because of her negative serum and urine protein electrophoresis.
If the patient initially presented to our institution infection would have been in the differential. Because the patient presented to our institution with pathologic specimens suggestive of a neoplastic process and negative lesion cultures, infection was considered unlikely.
Though primary sarcoma was included in the original differential, this was less likely given primary Ewing's sarcoma's predilection for other anatomic locations and younger patient population. Because the Ewing's sarcoma occurred in a 71-year-old patient, the initial treating physician at the outside facility assumed the tumor was metastatic disease and the patient was treated with a metastatic tumor dose of radiation (3500 Gy) immediately after the biopsy. However, additional workup revealed no evidence of a primary neoplasm outside of the involved T9 vertebra and the pathologic specimen was more consistent with a round cell neoplasm. Neuroblastoma is a common roundcell metastatic tumor but is rare after age 4 years. 6 Reverse transcriptase polymerase chain reaction results of the round cells indicated this lesion was Ewing's sarcoma.
The peak frequency of Ewing's sarcoma is during the adolescent growth spurt, and gender-based or race-based predilection is controversial. Bemporad et al 4 reported Ewing's sarcoma shows a male predominance and is rare in African Americans. The surveillance, epidemiology, and end results (SEER) data from 1973 to 1987 found 3.8% of all bone and joint tumors in African Americans were diagnosed as Ewing's sarcoma versus 17.2% of bone and joint tumors in Caucasian. 9 Dorfman et al 9 found Ewing's sarcoma in 17.6% of males with bone sarcomas and 13.8% of females with bone sarcomas. Ewing's sarcoma accounts for about 1% of all childhood tumors, yet it is the second most common primary malignant bone tumor; second only to osteosarcoma. 12 Eighty-eight percent of primary spinal Ewing's sarcoma patients are 20 years or younger with an average age of 16.5 years 2 and very rarely are cases ever reported younger than 5 years old or older than 30 years of age. Our patient is the oldest reported patient with primary Ewing's sarcoma of the spine.
The most common primary sites of origin for Ewing's sarcoma are the pelvic bones and the femur. 25 However, Ewing's sarcoma commonly metastasizes to lymph nodes, lungs, and other bones. 22 Though involvement of the spinal column is commonly seen in advanced stages of the disease, usually representing widespread metastases, primary vertebral Ewing's sarcoma is rare. It is only found in 3.5% to 15% of all cases. 3, 27, 28 The sacrum is most common primary spine site, ranging from 13% 18 to 53%. 15 The cervical spine is the least common site, accounting for less than 10% of cases. 11, 15, 19, 26 Clinical presentation of primary Ewing's sarcoma of the spine is a triad of back pain, neurologic deficit, and a palpable mass. 22 In a study by Pilepich et al, 18 of 22 patients, 14 patients had a neurologic deficit related to nerve root or spinal cord compression, four had a palpable mass, and all but one presented with back pain with a mean duration of 2.5 months. Constitutional symptoms such as fever, anemia, weight loss, and leukocytosis are also common. The literature suggests patients with lesions involving the rostral spine often present earlier than those in the caudal spine or sacrococcygeal area. 11, 18 The original biopsy was characteristic of Ewing's sarcoma, and RT-PCR confirmed the diagnosis. In this case EWS-FLI/EWS-ERG was the fusion product.
Most (93% 15 ) primary Ewing's sarcomas of the spine appear lytic and morphologically aggressive on imaging. Rarely, Ewing's sarcoma in the appendicular skeleton can be osteosclerotic, which corresponds histologically to necrotic and reactive bone formation. 23 The initial imaging evaluation of older patients with back pain is with plain radiographs. However, plain radiographs may appear negative or may be subtle in early stages of the disease. More advanced cross-sectional imaging with CT and/or MRI frequently supplies additional information. While CT is most helpful for evaluating the tumor matrix and cortical integrity, MRI is useful in determining soft tissue extension within the spinal canal and neural foraminal involvement (Fig 1) . Unusual imaging findings in Ewing's sarcoma, including solitary ivory vertebra 17 and pseudohemangioma, 4 have been reported in the literature, but our patient had neither.
Because of the nonspecific radiographic appearance of primary Ewing's sarcoma of the spine, it is often initially mistaken for many other disorders such as lumbar disc disease, 17 tuberculosis, 17 eosinophilic granuloma, 2 aneurysmal bone cyst, 4 neurogenic tumor, 4 giant cell tumor, 4 metastasis, 4 lymphoma, 4 and osteogenic sarcoma. 4 Early diagnosis and treatment are paramount because there are reports of a 100% local control rate and 80% disease-free survival in primary spinal tumors above the sacrum. 18 Prompt surgical decompression is essential for patients with progressive neurologic symptoms from epidural compression or if there is evidence of spinal instability to prevent irreversible neurologic defects. 22 Patients without severe or progressive neurologic deficits can receive preoperative chemotherapy before individualized surgery and/or radiation therapy. 22 Ewing's sarcomas are typically sensitive to chemotherapy and to radiotherapy. 14 Multiagent chemotherapy has made a substantial difference in the prognosis of Ewing's sarcoma, improving the 5-year survival from historical levels of 5% to 10% to more than 70%. Grubb et al 11 described a 5-year survival rate of 33% (mean survival time ‫ס‬ 2.9 years) for primary Ewing's sarcoma of the spine. Vincristine, cyclophosphamide, doxorubicin, iphosphamide, and etoposide are the common chemotherapeutic agents. Radiation therapy is still an alternative modality in treating Ewing's sarcoma locally in inoperable or metastatic Ewing's cases. However, ionizing radiation may play a role in the development of some post treatment osteosarcomas. 24 There is a debate as to whether surgery and chemotherapy or radiation and chemotherapy are the optimum treatment for patients with Ewing's sarcoma. At present, if the patient has metastatic disease or the tumor 
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Finstein et al cannot be radically excised with negative margins or is causing substantial morbidity to the patient, then chemotherapy and radiation therapy is recommended. 16, 21 Alternatively, if the opposite is true, preoperative chemotherapy followed by wide and/or radical surgical excision and subsequent postoperative chemotherapy may be the best treatment regimen. 21 Treatment was delayed because of the rarity of Ewing's sarcoma in this age group, the incorrect assumption it was metastatic lymphoma or carcinoma, the nondiagnostic nature of the imaging studies, and the time required to obtain the RT-PCR results. The patient's current treatment plan includes a chemotherapy experimental protocol and proton beam therapy. Radical resection with negative margins was not possible after her emergent decompression by neurosurgery because a large area of tissue contamination would have occurred through this procedure. Other medical factors, such as the patient's advanced age and proximity of a thoracic aortic aneurysm, also played a part in the decision to manage this patient's tumor with radiation and chemotherapy. At 6 months followup the patient was placed in hospice care because of additional metastases and deteriorating health.
This case of Ewing's sarcoma highlights the importance of thorough clinical examination, radiographic imaging, and histologic correlation in differential diagnosis of a patient with a vertebral mass. The definitive management of such a lesion should be decided after careful consideration of tumor extent (local or metastatic), surgical risk, functional outcome, and potential for long-term survival. This case also stresses the importance of proper workup in the patient with a solitary bone lesion before initiating therapy.
